U.S. President Donald Trump. Credit: The White House
President Donald Trump signed an executive order on April 15, aimed at reducing health care costs and providing substantial benefits to the pharmaceutical industry. While the order promises innovation and cost savings in the long run, it also presents immediate challenges for workers’ compensation and auto insurers.
The executive order introduces three major changes to the health care landscape. First, it extends the timeline for Medicare to negotiate prices for small molecule drugs from nine to 13 years, aligning the negotiation period with that of biologic drugs.
Recommended For You
Want to continue reading?
Become a Free PropertyCasualty360 Digital Reader
Your access to unlimited PropertyCasualty360 content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
